Anticoagulation management during veno-venous ECMO support because of ARDS: Single-center experience
Background: Patients with severe acute respiratory distress syndrome (ARDS) show a high mortality rate of up to 60 %. In such cases, extracorporeal membrane oxygenation (ECMO) support is often required, which would necessitate anticoagulation therapy, predominantly with heparin. Some bleeding events...
Saved in:
| Main Authors: | Boris Kuzmin, Max Wacker, Juliana Ponomarenko, Arevik Movsisyan, Florian Praetsch, Georg Marsch, Olaf Keyser, Mohammad Fadel, Maximilian Scherner, Jens Wippermann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024164481 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modified lung ultrasound score for improved monitoring of pARDS on ECMO, a case report
by: E. Küng, et al.
Published: (2025-01-01) -
The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMO
by: Mohamed Laimoud, et al.
Published: (2024-12-01) -
Comparison of integrated versus parallel continuous renal replacement therapy combined with veno-venous extracorporeal membrane oxygenation in patients with COVID-19 ARDS
by: Kristina Schönfelder, et al.
Published: (2025-01-01) -
Pre-assembled ECMO: Enhancing efficiency and reducing stress in refractory cardiac arrest care
by: Tharusan Thevathasan, et al.
Published: (2024-12-01) -
The superiority of veno-arterial over veno-venous extracorporeal membrane oxygenation for operative support of lung transplantation
by: Sen Lu, et al.
Published: (2025-01-01)